Clinical Trial Update: Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating celecoxib for non-muscle invasive bladder cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari | Conditions: Non Muscle Invasive Bladder Cancer | Phase 2 | Status: COMPLETED